SCHEMBL7470353

SCHEMBL7470353

CC(CN1CCN(c2ccc(Nc3ncc4c(n3)C(C3CCCC3)=C(O)CC4)cc2)CC1)C(N)C=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 10/20 0.43
CDK4 P11802 10/20 0.43
CCNA2 P20248 5/20 0.43
AURKA O14965 5/20 0.43
CDK6 Q00534 5/20 0.43
CCND3 P30281 3/20 0.43
CCNA1 P78396 2/20 0.43
PIM1 P11309 1/20 0.42
TTK P33981 1/20 0.42
PIM2 Q9P1W9 1/20 0.42
IGF1R P08069 1/20 0.40
CCND1 P24385 5/20 0.40
CCNE1 P24864 4/20 0.40
CDK1 P06493 3/20 0.40
CCNB1 P14635 2/20 0.40
SYK P43405 3/20 0.39
RPS6KA6 Q9UK32 1/20 0.39
INSR P06213 1/20 0.39
PDGFRB P09619 1/20 0.39
SRC P12931 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7475134 0.90 CDK4 (0.43) CDK2CDK4CCNA2AURKACDK6
SCHEMBL7469083 0.89 CDK2 (0.45) CDK2CDK4CCNA2AURKACDK6
SCHEMBL7462107 0.85 CDK2 (0.45) CDK2CDK4CCNA2AURKACDK6
SCHEMBL7475319 0.85 CDK2 (0.46) CDK2CDK4CCNA2AURKACDK6
SCHEMBL6087448 0.83 SYK (0.47) CDK2CDK4CCNA2AURKACDK6
SCHEMBL7475594 0.83 CDK2 (0.45) CDK2CDK4CCNA2AURKACDK6
SCHEMBL6088740 0.81 CDK2 (0.46) CDK2CDK4CCNA2AURKACDK6
SCHEMBL6089542 0.81 CDK4 (0.51) CDK2CDK4CCNA2AURKACDK6
SCHEMBL7470231 0.81 CDK2 (0.44) CDK2CDK4CCNA2AURKACDK6
SCHEMBL6086471 0.80 SYK (0.56) CDK2CDK4CCNA2AURKACDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235815-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2002-09-04 EP disclosed
WO-2001038315-A1 QUINAZOLINES AND THEIR USE FOR INHIBITING CYCLIN-DEPENDENT KINASE ENZYMES WARNER-LAMBERT COMPANY (US) 2001-05-31 WO disclosed